Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a Canadian company that specialises in transforming raw materials into pharmaceutical-grade contrast agents that can be used in medical imaging. Savin gives a brief summary of the note, titled "Voyageur Pharmaceuticals: Earthly profits from contrasting media."

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com